GL Pharm Tech Corp.
Founded and listed on KOSDAQ in 2014, GL Pharm Tech is an improved-new-drug pharmaceutical R&D company.
Price
Change
Market cap
Products & technology
- Cavalin CRNeuropathic pain treatment
- Acnon Cream, Palens EC tablets, Clearatin Ibu Double Spot TalcOTC and prescription drugs
- Dinax, famotidine tablets (GL Pharma)Anti-inflammatory and anti-ulcer drugs
- Alsaxen (GL Pharma)OTC drug for rheumatoid arthritis and osteoarthritis
Regulatory approvals
data.go.kr3 Korean MFDS drug approvals · 2019–2024
- MFDS drugKabalin CR Tab. 75mg(pregabalin)2024-05-07Drug · Prescription · Approval202401115
- MFDS drugKabalin CR Tab. 300mg(pregabalin)2019-01-11Drug · Prescription · Approval201900144
- MFDS drugKabalin CR Tab. 150mg(pregabalin)2019-01-11Drug · Prescription · Approval201900145
Clinical trials
data.go.kr23 MFDS clinical trial authorisations · 2012–2023 (Phase 1 21 · Phase 3 2)
- Phase 1GLM1RA2023-06-16
1 trial site
- Phase 1GLM1RA2023-05-22
1 trial site
- Phase 1GLM1RA2023-02-24
1 trial site
- Phase 1GLK2DS정(가칭)2021-03-22
1 trial site
- Phase 1GLH8NDE2019-07-23
1 trial site
- Phase 1GLA5PR GLARS-NF3정 75mg, 150mg2018-12-14
4 trial sites
- Phase 1GLH1SM 서방정2018-11-23
1 trial site
- Phase 1GLH1SM 서방정2018-11-22
1 trial site
- Phase 1GL2702 GLARS 정2016-04-29
1 trial site
- Phase 1GLA5PR2016-04-07
1 trial site
- Phase 1GLA5PR2016-04-07
1 trial site
- Phase 1GL29072015-09-04
1 trial site
Show 11 more
- Phase 1GLE1RCW정2015-06-29
1 trial site
- Phase 3GLE3PA2015-02-27
1 trial site
- Phase 1GLA5PR2014-05-13
1 trial site
- Phase 3GL2702 GLARS 정2013-11-14
1 trial site
- Phase 1GLA5PR2013-09-30
1 trial site
- Phase 1GL2702 GLARS 정2013-06-19
1 trial site
- Phase 1GL29072013-01-08
1 trial site
- Phase 1GL2702 GLARS 정2012-07-18
1 trial site
- Phase 1GLA5PR2012-07-04
1 trial site
- Phase 1GLA5PR2012-07-03
1 trial site
- Phase 1GL29072012-01-13
1 trial site
R&D and key agreements
Source: DART corporate disclosureGLM1RA · 라베프라졸·아스피린 복합제 · 기술이전(로열티 수취) · Licensed out to domestic/overseas pharma companies for royalty
GLL6TE · 테라조신 · 기술이전(로열티 수취) · Licensed out to domestic/overseas pharma companies for royalty
GLH8NDE · 안구건조증 · 임상3상 완료 · In-licensed from Dong-A ST in Nov 2017; Eupatiline-derivative new substance
지소렌정 · 위염(천연물) · 사업화 완료 · Patented improved extraction method; manufactured by Poongrim Muyak
Companies in the same categoryHealthcare Infrastructure
Supplies red ginseng, probiotics, and other health functional foods to 300+ clients via OEM/ODM.
Founded in 2014 and listed on KOSDAQ in 2024, Cellromax Science is a health functional food company built on a nationwide pharmacy network.
Founded and listed on KOSDAQ in 2014, KolmarBNH develops health functional food and cosmetics materials and provides ODM/OEM manufacturing.
CJ CheilJedang, founded and KOSPI-listed in 2007, operates food, BIO, and logistics businesses as a CJ Group intermediate holding company.
Founded in 1992 and listed on KOSPI in 2006, COSMAX BTI is the COSMAX Group holding company overseeing health food and cosmetics affiliates.
KOSDAQ-listed microbiome healthcare company using the PMAS gut-microbiome simulation platform and the PeachBiome028 probiotic strain.
Founded in 2000 and listed on KOSDAQ in 2018, Icure Pharmaceutical develops TDDS drug patches and cosmetics OEM/ODM.
Carelabs, founded in 2012 and KOSDAQ-listed in 2018, operates mobile healthcare and beauty care platforms.
Contract research organization providing clinical trial, post-marketing surveillance, and site management services to pharma and medtech clients.
Founded in 1998 and listed on KOSDAQ in 2021, S&D is a functional food ingredient company.
Founded in 1991 and listed on KOSDAQ in 2002, CosLeaguer Global distributes botulinum toxin and fillers and manufactures cosmetics.
Develops water-solubilized curcumin complexes for enhanced bioavailability using its WIN-T technology.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition